$14.77 +0.01 (0.07%) Ironwood Pharmaceuticals Inc - NASDAQ

Jan. 20, 2017 | 04:00 PM

Quotes

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Last Trade: 14.77
Trade Time: Jan 20 04:00 PM Eastern Daylight Time
Change: +0.01 (0.07%)
Prev Close: 14.76
Open: 14.77
Bid: 14.77
Ask: 14.78
  1. Allergan Outlook Improves On Good Trial For Colon Drug: Credit Suisse

    Investors Business Daily | Dec. 23, 2016 | 10:11AM EST
  2. Allergan Outlook Improves On Good Trial For Colon Drug: Credit Suisse

    Investors Business Daily | Dec. 23, 2016 | 10:11AM EST
  3. Ken Fisher's Best Investments: Credicorp, Ambev, Tata Motors

    GuruFocus | Jul. 11, 2016 | 04:31AM EST
  4. Benzinga's Top Initiations

    Benzinga | Jan. 8, 2016 | 09:37AM EST
  5. US Stock Futures Edge Lower Ahead Of Earnings

    Benzinga | Oct. 27, 2015 | 05:37AM EST
  6. Allergan Acquires Rights to Ironwood's CONSTELLA from Almirall 40+ Countries

    Benzinga | Oct. 27, 2015 | 03:15AM EST
  7. A Look at Steven Cohen's Investment in Ironwood Pharmaceuticals

    GuruFocus | Aug. 25, 2015 | 12:37PM EST
  8. Ironwood and Allergan Enter Agreement to Co-Promote VIBERZI for Irritable Bowel Syndrome with Diarrhea (IBS-D) in the U.S.

    Benzinga | Aug. 5, 2015 | 08:25AM EST
  9. Ironwood Progresses sGC Stimulator Platform with Positive Top-Line Phase I Data on IW-1973

    Benzinga | Jul. 22, 2015 | 06:34AM EST
  10. Benzinga's Top #PreMarket Gainers

    Benzinga | Jul. 8, 2015 | 07:12AM EST
  11. Sucampo Stock Rebounds As Drug Gets Fast-Track Review

    IBD | May. 8, 2015 | 10:11AM EST
  12. The World's Top 10 Financial Bloggers

    GuruFocus | Jan. 12, 2015 | 16:36PM EST
  13. Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 1

    Benzinga | Jan. 12, 2015 | 08:55AM EST
  14. Ironwood Presents IW-9179 Phase IIa Data At American College Of Gastroenterology 2014 Annual Scientific Meeting

    Benzinga | Oct. 20, 2014 | 07:09AM EST
  15. Ardelyx Bowel Drug Could Rival Actavis' Linzess

    IBD | Oct. 1, 2014 | 11:10AM EST
Trading Center